Scotia Capital Inc. Invests $281,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Scotia Capital Inc. acquired a new position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 472 shares of the biotechnology company's stock, valued at approximately $281,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in AXON. Asset Dedication LLC grew its stake in shares of Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after buying an additional 18 shares during the last quarter. Bleakley Financial Group LLC grew its stake in Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after purchasing an additional 20 shares in the last quarter. Venturi Wealth Management LLC raised its holdings in shares of Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after acquiring an additional 21 shares in the last quarter. Burns Matteson Capital Management LLC boosted its stake in shares of Axon Enterprise by 3.4% during the fourth quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company's stock valued at $450,000 after purchasing an additional 25 shares in the last quarter. Finally, Transcend Capital Advisors LLC increased its holdings in shares of Axon Enterprise by 3.6% in the 4th quarter. Transcend Capital Advisors LLC now owns 726 shares of the biotechnology company's stock valued at $431,000 after acquiring an additional 25 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON traded down $12.32 during trading on Friday, hitting $559.53. 519,604 shares of the stock traded hands, compared to its average volume of 796,658. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market cap of $42.87 billion, a price-to-earnings ratio of 144.58, a P/E/G ratio of 5.17 and a beta of 1.13. The company has a fifty day moving average price of $556.27 and a two-hundred day moving average price of $565.34.

Analysts Set New Price Targets

Several equities research analysts have weighed in on AXON shares. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Needham & Company LLC reissued a "buy" rating and set a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 26th. TD Cowen started coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target for the company. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. Finally, JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and an average price target of $626.45.

Insider Buying and Selling at Axon Enterprise

In other news, Director Jeri Williams sold 307 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 6.10% of the stock is owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.